A Study of Intratumoral CAVATAK™ in Patients With Stage IIIc and Stage IV Malignant Melanoma (VLA-007 CALM )

Clinical trial NCT01227551 · COMPLETED

Trial details

NCT number: NCT01227551
Sponsor: Viralytics
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Malignant Melanoma

Start date: 2011-12-29
Primary completion: 2016-04-06
Enrollment: 57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.